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Human papillomavirus (HPV) is well recognized as a causative agent for anogenital and oropharyngeal
cancers, however, the biology of HPV infection at different mucosal locations, speciﬁcally the oral cavity,
is not well understood. Importantly, it has yet to be determined if oral tissues are permissive for HPV
infection and replication. We investigated for the ﬁrst time the titers, infectivity, and maturation of
HPV16 in oral epithelial versus genital epithelial tissue. We show that infectious HPV16 virions can be
produced in oral tissue. This demonstrates, for the ﬁrst time, that infectious virus could be spread via the
oral cavity. HPV16 derived from oral tissue utilize a tissue-spanning redox gradient that facilitates the
maturation of virions over time. Maturation is manifested by virion stability and increased susceptibility
to neutralization with anti-HPV16 L1 antibodies. However, susceptibility to neutralization by anti-HPV16
L2 speciﬁc antibodies decreases during the maturation of HPV16 virions in oral tissue.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In a recent report to the nation published in the Journal of the
National Cancer Institute, it was reported that death rates con-
tinued to decline for all cancers combined for men and women of
all major racial and ethnic groups and for most major cancer sites
(Jemal et al., 2013). However, the incidence rates increased for
oropharynx human papillomavirus- (HPV-) associated cancers
(Jemal et al., 2013). There have also been substantial changes in
the burden of cancer affecting HIV-infected individuals in the U.S.
during a 12-year period spanning the introduction of highly active
anti-retroviral therapy (HAART). As a result of these temporal
changes, non-AIDS-deﬁning malignancies have come to comprise
the majority of cancers in HIV-infected persons during the HAART
era (Engels et al., 2008). Among these emerging malignancies,
HPV-associated cancers of the oral cavity/pharynx increased sig-
niﬁcantly following an AIDS diagnosis (Engels et al., 2008; Grulich
et al., 2010). HPV is rapidly changing the landscape of head and
neck squamous cell carcinoma (HNSCC). However, the mechan-
isms and natural history of oral HPV infection and oncogenic
progression is poorly understood. Extrapolation of knowledge of
HPV-associated infection and oncogenicity in the genital tract isInc. This is an open access article u
.not satisfactory to our understanding of oral HPV disease. HPV is
necessary, but not sufﬁcient, to cause invasive cervical cancer.
Although HPV is an important cause of oropharyngeal cancer, HPV
infection is neither necessary nor sufﬁcient to cause HNSCC that
can occur in the absence of HPV. Therefore, HPV-HNSCC needs to
be studied as its own entity.
HPV16 is the most dominant HPV type, accounting for (490%)
HPV-associated HNSCCs. HPV16 is also the same type that com-
monly leads to HPV-associated anogenital cancers (Marur et al.,
2010). While the lifecycle of HPV16 has been extensively studied in
anogenital tissues, little has been reported on the HPV16 life cycle
in oral tissues. In fact, direct evidence that oral tissue can support
HPV replication of infectious virus particles is lacking.2. Methods
2.1. Keratinocyte cultures and generation of cell lines
Primary human tonsil (HTLK) and primary human foreskin
keratinocytes (HFK) were isolated and grown from tonsil and
foreskin tissues, respectively, according to the method described
previously (Conway et al., 2009a, 2009b). HPV16þ cell lines were
generated as previously described (McLaughlin-Drubin et al.,
2004). In short, pBSHPV16 plasmid DNA was digested with BamH1
to linearize the viral DNA and separate it from the vector sequence.
A total of 10 mg viral DNA was electroporated into HTLKs or HFKsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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et al., 2009a, 2009b). Immortalized keratinocytes stably main-
taining HPV16 genomes following electroporation were cultured
with J2 3T3 feeder cells and maintained in E-medium.
2.2. Southern blot hybridization
Immortalized HTLK cell lines were characterized by Southern
blot hybridization, as previously described, to determine the state
and quantity of the HPV16 genome within the immortalized ker-
atinocytes (Meyers et al., 1992a). Brieﬂy, total cellular DNA was
isolated from the immortalized cell line. To linearize the viral
genome, 5 μg of the total cellular DNA was digested with BamHI.
Samples were then separated by gel electrophoresis on a 0.8%
agarose gel, transferred onto a GeneScreen Plus membrane (New
England Nuclear Research Products) and probed with a HPV16
speciﬁc, whole genome probe, as previously described
(McLaughlin-Drubin et al., 2004, 2003; Meyers et al., 1992a, 1997).
2.3. Production of native HPV in organotypic raft cultures
Organotypic (raft) cultures were grown as previously described
(Meyers et al., 1992a, 1997). Immortalized HTLK and HFK lines
persistently infected with HPV16 were seeded onto collagen ma-
trices consisting of rat-tail type 1 collagen and containing J2 3T3
feeder cells. Following cell attachment and growth to conﬂuence,
the matrices were lifted onto stainless steel grids and fed with
E-medium supplemented with 10 μM 1,2-dioctanoyl-sn-glycerol
(C8:O; Sigma Chemical Company) via diffusion from below. Raft
cultures were allowed to stratify and differentiate for 10 days, 15
days, or 20 days.
2.4. Histochemical analyses
Raft culture tissues were harvested at different time points,
ﬁxed in 10% neutral buffered formalin, and embedded in parafﬁn.
Four-micrometer sections were cut and stained with hematoxylin
and eosin (H&E) (Meyers et al., 1992b, 1997).
2.5. HPV Isolation and optiprep puriﬁcation of virions
HPV infected raft tissues were harvested as has been described
(Conway et al., 2009a, 2009b, 2011a, b). Viral preparations (VPs)
were prepared as previously described (Conway et al., 2009a,
2009b, 2011a, b; Cruz and Meyers, 2013). Brieﬂy, two rafts were
dounce homogenized in 500 μl of phosphate buffer (0.05 M so-
dium phosphate [pH 8.0]/2 mM MgCl2). Homogenizers were
rinsed with 250 μl of phosphate buffer. Then, un-protected gen-
omes were digested by the addition of 1.5 μl (375 U) of benzonase
to 750 μl of VP, followed by incubation at 37 °C for 1 h. Samples
were brought to 1 M NaCl by adding 188 μl of ice-cold 5 M NaCl.
Then, samples were vortexed and centrifuged at 4 °C and
10,500 rpm for 10 min. The supernatants were stored at 80 °C
for further experiments. Optiprep puriﬁcation was performed as
described previously (Conway et al., 2009a, 2009b, 2011a, b).
Brieﬂy, OptiPrep gradients were prepared by underlaying 27%,
33%, and 39% Optiprep. Gradients were allowed to diffuse for 1 h at
room temperature. Then, 600 μl of clariﬁed, benzonase-treated
virus preps was layered on top of the gradient. Tubes were then
centrifuged in a SW55 rotor (Beckman) at 234,000 g for 3.5 h at
16 °C. After centrifugation, 11–500 μl fractions were carefully col-
lected, top to bottom, from each tube.2.6. Titration of HPV16
HPV16 titers were measured as previously described (Conway
et al., 2009a, 2009b, 2011a, b; Cruz and Meyers, 2013). Brieﬂy, viral
genomes were released from a benzonase treated virus prepara-
tion by re-suspension in 200 μl HPRT DNA extraction buffer
(400 mM NaCl /10 mM Tris-HCl [pH 7.4]/10 mM EDTA, pH 8.0),
2 μl 20 mg/ml proteinase K, and 10 μl 10% SDS for 2–4 h at 37 °C.
Following extraction, the DNA was puriﬁed by phenol-chloroform
extraction and ethanol precipitated overnight at 20 °C. To
quantify the viral genomes, a Thermo Scientiﬁc Maxima SYBR
Green qPCR kit was utilized. Ampliﬁcation of the HPV16 E2 open
reading frame (ORF) was performed using 0.3 μM of forward pri-
mer 5′-CCATATAGACTATTGGAAACACATGCGCC-3′ (nucleotides
(Zhao et al., 2000) 2839 to 2868) and 0.3 μM of reverse primer 5′-
CGTTAGTTGCAGTTCAATTGCTTGTAATGC-3′ (nt 2960 to 2989).
Ampliﬁcation of the E2 ORF of serially diluted pBSHPV16 DNA,
ranging from 108104 copies/μl served to generate a standard
curve. A Bio-Rad iQ5 Multicolor Real-Time qPCR machine and
software were utilized for PCR ampliﬁcations and subsequent data
analysis.
2.7. Infectivity assays
All infectivity studies were performed using HaCaT keratino-
cytes. HaCaT cells were seeded 50,000 cells/well in 24-well plates
and infectivity assays were performed as previously described
(Conway et al., 2009a, 2009b, 2011a, b; Cruz and Meyers, 2013).
Brieﬂy, cells were incubated with virus for 48 h at 37 °C/5% CO2
followed by mRNA harvest using a RNeasy kit (Qiagen). Infections
were analyzed using a RT-qPCR based assay detecting levels of the
E1^E4 splice transcript. HPV16 E1^E4 was detected using the for-
ward primer 5′-GCTGATCCTAGCAACGAAGTATC-3′, the reverse
primer 5′-TTCTTCGGGTGCCCAAAGGC-3′, and the probe 5′- (6-
FAM)CCCGCCGCGACCCATACCAAAGCC(BHQ-1)-3′. For neutraliza-
tion assays, virus was incubated for 1 h at 37 °C prior to infection
with the conformation-dependent anti-L1 antibody H16. V5
(1:1000 dilution; a kind gifts from Neil Christensen, Penn State
College of Medicine) or the anti-L2 antibodies RG-1 (1:100 dilu-
tion; a kind gift from Richard Roden, Johns Hopkins) and L2#4
(1:100 dilution; a kind gift from Tadahito Kanda, the RIKEN in-
stitute) followed by the infectivity assay as described previously
(Conway et al., 2009a, 2009b, 2011a, b; Cruz and Meyers, 2013).
2.8. Western blot analysis
Aliquots (70 μl) from OptiPrep fractions were boiled for 10 min
in 6% 2-mercaptoethanol (2-ME) loading buffer and then loaded
onto 8–12% polyacrylamide gels. To detect HPV16 L1, the Camvir-1
anti-HPV16 L1 monoclonal antibody (BD Pharmingen) was used at
a dilution of 1: 2500 according to the manufacturer’s re-
commendations. To determine the relative quantity of L1 present
in the bands, a Bio-Rad G8-800 calibrated densitometer along with
Quantity One analysis software was used.
2.9. Identiﬁcation of free sulfhydryls and disulﬁde bonds
Frozen sections of HPV16-infected tonsil and foreskin epithelial
tissue were stained with DACM (N-[7-Dimethylamino-4-Methyl-
coumarinyl]-Maleimide) to detect free sulfhydryls and disulﬁde
bond-speciﬁc sulfhydryls as previously described (Ogawa and Ta-
neda, 1979; Ogawa et al., 1979). Tissue sections were imaged on a
Nikon Eclipse 80i microscope and images were taken with a
CoolSnap Cf2 camera and NIS-elements 3.10 software.
Fig. 1. Establishment of productive HPV16 cell lines from tonsil tissue. (A) Southern blot of a HPV16 HTLK cell line. The HPV16 genome isolated from HPV16 immortalized
tonsil cells shows un-cut or BamHI cut HPV16 genomes. Copy controls represent the number of viral genome copies per 5 μg of total cellular DNA that was loaded in lanes
un-cut and BamHI cut. Form I is supercoiled viral DNA, Form II is nicked viral DNA, and Form III is linear viral DNA. (B) H&E staining of uninfected, and HPV16 infected 10-d,
15-d, and 20-d tonsil (i–iv) and foreskin (v–viii) organotypic raft tissue. Images shown are from the same immortalized HTLK and HFK cell lines and are representative of
multiple HTLK and HFK cell lines.
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3.1. Development of HPV16 stable cell lines and growth in organo-
typic cultures
To develop producer cell lines derived from tonsil and foreskin
keratinocytes, primary tonsil (HTLK) and foreskin keratinocytes
(HFK) were electroporated with wild-type HPV16 genomes. To
account for potential host differences, the HPV16 genome was
electroporated into multiple batches of HTLKs and HFKs and
multiple cell lines for each cell type were selected by im-
mortalization as measured by greater than 20 population dou-
blings. The maintenance of episomal HPV16 genomes in the im-
mortalized cell lines was conﬁrmed by Southern blot. The HPV16
HTLK cell lines generated stably maintain approximately 100
episomal copies of HPV16 DNA per cell (Fig. 1A). These HPV16
persistently ‘infected’ cell lines were then grown in organotypic
culture. The organotypic tissues were harvested after 10-, 15- and
20-days of growth. H&E staining shows that the HPV infection
slightly disturbs differentiation morphology as compared to the
uninfected tissues (Fig. 1B). Unlike epithelia in vivo, organotypictissues are always horizontal and dead cells are not sloughed off,
leading to a buildup of the corniﬁed layer of tissue, which displays
an increased thickness over time. Therefore, the accumulation of
cells in the top, corniﬁed layer is much thicker than what you
would observe from epithelia in vivo. The HPV16 infected tonsil
tissues has large amounts of vacuolated cells in the upper strata,
similar to uninfected tonsil tissue (Fig. 1B i-iv). The HPV16 infected
foreskin tissue often has a thickened top layer composed of cor-
niﬁed cells (Fig. 1B v-viii) as we have previously demonstrated
(McLaughlin-Drubin et al., 2004, 2003; Meyers et al., 1997).
3.2. Viral titers and infectivity
To compare the production of HPV16 virions in foreskin versus
tonsil epithelia, we measured viral titers after 10-, 15- and 20-days
of organotypic tissue growth (Fig. 2A and B). HPV16 virion pro-
duction in tonsil tissue showed a time dependent increase in the
quantity of encapsidated, endonuclease resistant genomes. HPV16
replication in foreskin tissue peaked after 15-days of tissue growth
then dropped about 1/3rd after 20-days of tissue growth, as we
have previously reported for foreskin tissue (Conway et al., 2009b).
Fig. 2. HPV16 titers and infectivity increase in a time dependent manner. Titration of HPV16 virus preparations derived from tonsil (A) and foreskin (B) organotypic raft
tissue at 10-days, 15-days, and 20-days of tissue growth. Virus preparations were treated with benzonase to ensure the presence of only encapsidated viral genomes followed
by quantiﬁcation by qPCR against a standard curve of known concentrations of HPV16 DNA. HaCaT cells were infected with HPV16 virions (VGE¼5) isolated from 10-d, 15-d,
and 20-d tonsil (C) and foreskin (D) organotypic raft tissue. Forty-eight hours post-infection, mRNA was harvested and infection was measured via qRT-PCR ampliﬁcation of
the HPV E1^E4 splice transcript. The level of Infection is relative, with 10-d virus infection levels being set equal to 1.
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foreskin tissues, we infected HaCaT cells with equal viral genome
equivalents (VGEs) of 5 and measured infectivity by RT-qPCR as
previously described (Conway et al., 2009a, 2009b, 2011a, b; Cruz
and Meyers, 2013). The level of infectivity for 15-d and 20-d virus
is shown as relative infectivity, compared to the infectivity of 10-d
virus. The infectivity efﬁciency of HPV16 increased in a time de-
pendent manner (Fig. 2C and D) for virus grown in both tissues,
similar to what we previously reported for HPV16 in foreskin tis-
sue (Conway et al., 2009b). HPV16 from foreskin tissue grown for
15-days demonstrated a 50% increase in infectivity over 10-d virus,
while HPV16 infection from 20-d foreskin tissue was nearly twice
as efﬁcient as virus from 15-d foreskin tissues (Fig. 2D). Time de-
pendent changes in infectivity of HPV16 grown in tonsil tissues for
10-, 15-, and 20-days differed in relative changes in infection, with
15-d and 20-d HPV16 showing 7-times and 10-times more relative
infectivity than virus from 10-d tissues (Fig. 2C). There has always
been speculation that the oral cavity could replicate and spread
infectious HPV. However, assays previously performed only mea-
sured the presence of viral genomes. This is the ﬁrst direct evi-
dence that oral tissues can replicate infectious HPV.
3.3. HPV16 stability and maturation
To assess potential differences in stability and maturation be-
tween HPV16 grown in tonsil and foreskin tissues, we fractionated
the viral preparations on OptiPrep step gradients and then mea-
sured viral titers and infectivity in each fraction. OptiPrep gradient
fractionation of HPV virions has been reported to destabilize
capsids (Buck et al., 2004; Conway et al., 2009a, 2009b, 2011b). The
majority of viral genomes from fractionated 10-d foreskin tissue
derived HPV16 was detected in fractions 1-4 rather than in the
high infectivity fractions 6-8 (Conway et al., 2009a, 2009b, 2011a,b; Cruz and Meyers, 2013), suggesting that high shear forces and
hydrostatic pressure associated with ultracentrifugation may have
led to the destruction of capsids, as suggested by other studies
(Buck et al., 2005). When 15- and 20-d foreskin tissue derived
HPV16 were OptiPrep fractionated and viral genomes quantitated,
viral genomes were less prevalent in fractions 1-4 and more pre-
valent in the denser fractions 5-9, suggesting that 15- and 20-d
virions were more stable than 10-d virions (Fig. 3B), similar to
what we have previously reported (Conway et al., 2009a, 2009b,
2011a, b). Conversely, HPV16 derived from tonsil tissues showed
an OptiPrep gradient proﬁle different from the foreskin derived
HPV16 (Fig. 3A). After 10-days of tonsil tissue growth, the virus
particles were spread evenly across all gradient fractions, sug-
gesting an equal mixture of viral particles at all levels of stability.
As the tonsil tissue growth time increased to 15- and 20-days, the
virus particles shifted to having the highest proportions of parti-
cles being in fractions 6–8, the more stable fractions (Fig. 3A). This
suggests a fundamental difference between HPV16 grown in tonsil
and foreskin tissues. HPV16 maturation in tonsil epithelium ap-
pears to occur earlier and to a greater percentage of the total virus
than what is observed with HPV16 grown in foreskin tissues.
As a method to quantify the relative stability of particles within
virus preparations, the ratio of unstably encapsidated viral gen-
omes (fractions 1-4) over stably encapsidated viral genomes
(fractions 6-8) was taken. In foreskin derived HPV16 viral pre-
parations, we detected 14.8, 1.0 and 0.56 unstably encapsidated
viral genomes for every stably encapsidated viral genome in 10-,
15-, and 20-d tissue, respectively (Fig. 3C). This data suggests that
many more unstably encapsidated virions exist in 10-d foreskin
tissues compared to 15- and 20-d foreskin tissues. This is similar to
what we have previously reported (Conway et al., 2009b, 2011b).
We then compared the relative stability of HPV16 grown in tonsil
tissues and measured ratios of 2.7, 0.48, and 0.34 unstably
Fig. 3. HPV16 genomes are stabilized over time. Endonuclease resistant genomes derived from tonsil (A) and foreskin (B) organotypic raft tissue grown for 10-days (black
bars), 15-days (gray bars), and 20-days (white bars) were loaded onto an Opti-Prep gradient and ultracentrifuged. qPCR was then utilized to quantify the amount of HPV16
DNA in each fraction (fraction 1¼top, fraction 11¼bottom). (C) The relative stability of HPV16 virions, derived from tissue grown for 10-days, 15-days, or 20-days for both
tonsil and foreskin tissue.
Fig. 4. Infectivity of the OptiPrep fractionated HPV16. RT-qPCR infectivity assay of 10 (black bars), 15 (gray bars), and 20-d (white bars) OptiPrep-fractionated (A) tonsil and
(B) foreskin HPV16 VP (fractions 1–11). (C) Western blot analysis of HPV16 L1 protein in fractions 6–8 from OptiPrep-fractionated 10, 15, and 20-d HPV16 VPs. The table shows
the relative infectivity, the relative total protein via densitometry, and the speciﬁc infectivity (infectivity-to-protein ratio) of fraction 7. Both the fractionation and WB were
done in duplicate, with the same trend being present. The results shown here are representative of duplicate experiments.
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genome in 10-, 15-, and 20-d tissue, respectively (Fig. 3C). This
ﬁnding suggests that HPV16 is able to mature faster to become a
more stable virion in tonsil epithelium than in foreskin epithelium.
We utilized RT-qPCR to compare infectivity of virions extracted
from 10-, 15-, and 20-d foreskin and tonsil tissues (Fig. 4). In order
to obtain infectivity from all fractions of the 10-, 15- and 20-d an
equal VGE of 10 was used for all infectivity assays. In contrast to
the stability proﬁles, the infectivity proﬁles of OptiPrep fractio-
nated HPV16 from 10-, 15-, and 20-d tonsil and foreskin tissues
very similar (Fig. 4A and B). The infectivity proﬁles show that
HPV16, at all growth periods and from either tissue, had the
highest levels of infectivity in fractions 5-8, as we had previously
shown for foreskin tissues (Conway et al., 2009b). As expected
from the stability proﬁles, the greatest relative infectivity was
observed in the virus grown for 20-days. Infectivity observed in
the unstable fractions, 1–4, is at levels similar to what we have
observed with free viral genomes (Conway et al., 2009b).
To determine whether stability of virions played a role in the
observed increase in speciﬁc infectivity, Western blot analysis ofFig. 5. Detection of disulﬁde bonds in 15-d HPV16 infected (A) tonsil and (B) foreskin
blocked with NEM prior to DACM stain. (iii) Free sulfhydryl groups stained with DAC
dithiothreitol ﬁrst followed by DACM stain. (v) Disulﬁde- bonded sulfhydryl groups stai
followed by DACM stain. The lower, dashed white line represents the line between the b
represents the start of the corniﬁed layer of tissue.the L1 capsid protein from OptiPrep-fractionated 10-, 15-, and 20-d
HPV16 preparations was performed. The relative quantity of L1
expression in gradient fraction 7 in 10-, 15-, and 20-d preparations
was used to normalize for relative infectivity of these same frac-
tions. This was done to deﬁne the “infectivity-to-protein ratio” as a
second gauge for speciﬁc infectivity. Previously, we have shown
that 20-d foreskin derived HPV16 was 2.9-fold more infectious
than 10-d HPV16, suggesting that there is an intrinsic difference
between 10- and 20-d HPV16 taken from fraction 7 rather than a
difference in the overall stability of particles within 10-, 15-, and
20-d foreskin tissue preparations (Conway et al., 2009b). Western
blot analysis of L1 from OptiPrep-fractionated 10-, 15-, and 20-d
tonsil derived HPV16 were performed. The infectivity-to-protein
ratio for tonsil derived HPV16 showed that 20-d HPV16 was 3.1-
fold more infectious than 10-d HPV16 (Fig. 4C).
Formerly, in HPV16 extracted from foreskin tissues we found by
Western blot two bands representing two different sizes of capsid
derived L1 in OptiPrep fractions 6–8 (Conway et al., 2009b). Here we
found that, like foreskin tissue, the L1 protein from HPV16 particles
derived from tonsil tissue also exists as two bands (Fig. 4C).organotypic tissue via DACM staining. (i) Unstained tissue. (ii) Sulfhydryl groups
M. (iv) Free and disulﬁde- bonded sulfhydryl groups stained by treatment with
ned by blocking with NEM, followed by treatment with dithiothretol ﬁrst and then
asal cells and the collagen plug the tissue is grown on. The upper, dotted white line
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The highly oxidizing environment of the stratum corneum
compared to suprabasal strata allowed us to hypothesize that the
temporal phenotypic changes observed over time were due to the
exposure of virions to the different redox environments of epi-
thelium (Buck et al., 2005; Ogawa et al., 1979; Pang et al., 1993).
We have previously reported that in foreskin epithelial raft tissues,
similar to what has been observed in vivo, a differential localiza-
tion of free versus disulﬁde-bonded sulfhydryls conﬁrmed that a
natural redox gradient exists within human foreskin epithelial
tissue whereby the basal and suprabasal compartments can be
generally described as reducing while the corniﬁed compartment
is oxidizing (Conway et al., 2009b). To conﬁrm that tonsil epithelia
have a similar reducing and oxidizing environment, frozen sec-
tions of 15- and 20-d (Fig. 5 and data not shown, respectively)
HPV16-infected tonsil and foreskin epithelia were stained with the
ﬂuorescent, sulfhydryl-alkylating, reagent, DACM. DACM is not
ﬂuorescent until it reacts with free sulfhydryl groups, thus emit-
ting a ﬂuorescent color (Ogawa et al., 1979; Pang et al., 1993). We
detected that all epithelial strata, except the stratum corneum,
contained signiﬁcant amounts of detectable free sulfhydryl groups
when stained with DACM alone (Fig. 5A-iii and B-iii). Treatment
with DTT to break all disulﬁde bonds, followed by staining with
DACM showed that sulfhydral groups are found in all strata
(Fig. 5A-iv and B-iv). Whenwe irreversibly blocked free sulfhydryls
with the sulfhydryl-alkylating reagent N-ethylmaleimide (NEM),
followed by reduction of disulﬁde-bonded sulfhydryls with di-
thiothreitol and then stained with DACM, only the stratum cor-
neum contained signiﬁcant amounts of detectable disulﬁde bonds
(Figs. 5A-v and B-v). Only faint auto-ﬂuorescent signals can be
detected in either unstained samples or samples blocked with the
NEM (Fig. 5A-i and ii and B-i and ii). The differential localization of
free versus disulﬁde-bonded sulfhydryls conﬁrms that a natural
redox gradient exists within human tonsil epithelial tissue
whereby the basal and suprabasal compartments can be generally
described as reducing, while the corniﬁed compartment is oxi-
dizing. At 10-days, most of the virus is found within the reducing
compartment of the host tissue. At 15-days, the virus has migrated
into the oxidizing (corniﬁed) compartment of the host tissue,
therefore allowing for disulﬁde bonding to occur within the viral
capsid, stabilizing the particle (Conway et al., 2009b, 2011b).
3.5. Susceptibility to neutralization by antibodies speciﬁc for L1 and
L2 capsid proteins
Previously, we detected a differential susceptibility to neu-
tralization by anti-L1 and anti-L2 antibodies in virions isolated atFig. 6. Antibody mediated neutralization of tonsil tissue. (A) Neutralization of 20-d to
conﬁrmation dependent anti-HPV16 L1 antibody H16.V5 (at a dilution of 1:1000) and t
(B) Neutralization of 20-d foreskin (black bars) and multiple, separate preparations (eac
HPV16 virions using the conﬁrmation dependent anti-HPV16 L1 antibody H16.V5 (at a di
a dilution of 1:100).different time points from foreskin tissues (Conway et al., 2009a,
2009b, 2011a). We tested whether tonsil tissue derived HPV16
showed a similar differential susceptibility to neutralization. A VGE
of 10 was used for all neutralization assays. We used the con-
formation dependent anti-L1 MAb H16. V5 (epitope amino acids
266–297 and 335–365) (Christensen et al., 2001), the anti-L2 MAb
RG1 (epitope amino acids 17–36) (Gambhira et al., 2007), and the
anti-L2 antiserum L2#4 (epitope amino acids 56–75) to test the
neutralization proﬁles of HPV16 derived from tissues grown for
20-days.
As previously reported, infection by foreskin tissue-derived
HPV16 grown for 20-days was efﬁciently neutralized by all three
antibodies utilized. In contrast, the tonsil derived HPV16 was ef-
ﬁciently neutralized by the L1 antibody, H16. V5 and only mod-
erately neutralized by either of the L2 speciﬁc antibodies (Fig. 6A).
Additionally, as indicated by the large error bars present, the tonsil
tissue showed a wide variation in its ability to be neutralized with
all three antibodies tested. Therefore, virus from four different
HTLK cell lines, each derived from an individual patient sample,
was tested for infectivity and neutralization utilizing the L1 and L2
speciﬁc antibodies previously mentioned (Fig. 6B). Overall, tonsil-
derived HPV16 was neutralized by the conformation dependent
anti-L1 H16. V5 antibody. However, this neutralization was not as
efﬁcient as the neutralization of infection by foreskin-tissue de-
rived HPV16 (Fig. 6A). Additionally, when neutralization by H16.
V5 was tested on the individual tonsil preparations, only two of
the four samples were neutralizable, indicating variation between
virus preparations from different tonsil tissue samples (Fig. 6B).
Neutralization with both of the L2 speciﬁc MAbs was only mod-
erately neutralizable overall (Fig. 6A) and was also highly variable
between virus preparations, as can be seen when looking at neu-
tralization of virus from cell lines created from individual patient
tissue (Fig. 6B). Since tonsil tissue-derived HPV16 is highly in-
fectious and shows an OptiPrep gradient proﬁle similar to foreskin
tissue-derived HPV16 virus, this strongly suggests a conforma-
tional difference between foreskin derived and tonsil derived
HPV16.4. Discussion
Viral capsids are typically composed of numerous repeating
identical or of a few different species of subunits. These subunits
are arranged in precisely arranged patterns. Commonly, the ﬁrst
form that can be observed with the electron microscope is the
capsomere. Multiple capsomers come together to form the viral
capsid. The simplicity of the capsid minimizes the space on the
viral nucleic acid necessary for it's coding and increases thensil (gray bars) and foreskin (black bars) tissue-derived HPV16 virions using the
he anti-HPV16 L2-speciﬁc antibodies RG-1 and L2#4 (both at a dilution of 1:100).
h from an individual patient sample) of tonsil (gray and white bars) tissue-derived
lution of 1:1000) and the anti-HPV16 L2-speciﬁc antibodies RG-1 and L2#4 (both at
M. Israr et al. / Virology 499 (2016) 82–90 89efﬁciency of assembly. The two main functions of the capsid are to
protect viral genomes from the extracellular environment and to
deliver the genomes from one cell or host to the next. While the
general instructions for capsid assembly may on the surface ap-
pear simple, the host environment can induce numerous potential
changes in the stability and efﬁciency of assembly. Additionally,
there is the potential for the host cell environment or the extra-
cellular environment to induce changes in the viral surface con-
formation that can then affect binding efﬁciency to a naïve host
cells, immune interactions, and/or disassembly of the virus within
a new host cell. Examples of this are numerous with enveloped
viruses, with changes in enveloped proteins affecting infectivity
and surveillance by the immune system. Little has been reported
for a similar phenomenon with non-enveloped viruses. In our
present study, we demonstrate that while much of the phenotype
of HPV16 grown in foreskin and tonsil tissue is similar, virus de-
rived from the two tissues differs in two signiﬁcant ways. First, a
greater percentage of the total HPV16 virions grown in tonsil
epithelium become fully mature and stable and this occurs faster
than what is observed with HPV16 virions grown in foreskin tis-
sue. Similar differentiation associated redox potential gradients,
which we have previously shown to be important for the stability
and maturation of HPV16 (Conway et al., 2009a, 2009b, 2011b), are
shown for both tissue types. However, the stability and maturation
of virus from foreskin and tonsil differ, suggesting the involvement
of other host cell factors in virion assembly and maturation. It is
possible that there are cell type speciﬁc chaperones that assist in
viral capsid assembly, though future investigations are needed to
determine this. The second major phenotypic difference between
viruses from tonsil versus foreskin is the overall inability of L2-
speciﬁc antibodies to neutralize tonsil-derived virus. This suggests
that the ﬁnal surface conformation of the tonsil-derived HPV16
differs at least in respect to the capsid conformation and avail-
ability of L2. Additionally, the difference in neutralization proﬁles
between virus preparations produced from different HTLK cell
lines indicates that not all tonsil-tissue derived virions are struc-
turally identical. Interestingly, the surface conformation of the L1
capsid protein did not appear to differ, as both foreskin and tonsil
derived virions are susceptible to neutralization by the con-
formational dependent L1 antibody.
The HPV life cycle is intimately connected to the differentiation
program of its host tissue, squamous epithelium. Using the orga-
notypic culture system, our laboratory has previously studied the
life cycle of different HPV types in genital tissues (Conway et al.,
2009a, 2009b, 2011a, b; McLaughlin-Drubin et al., 2005, 2004;
McLaughlin-Drubin and Meyers, 2004, 2005; Meyers et al., 1992a,
1997; Ozbun and Butel, 1995; Ozbun and Meyers, 1996, 1997,
1998a, b, 1999). In the present study, we investigated for the ﬁrst
time the life cycle of HPV16 in oral tissue with direct comparison
to foreskin tissue. While it has commonly been believed that the
oral cavity is capable of replicating infectious HPV particles and
therefore a source of viral spread, this has never been directly
demonstrated. We have shown here that tonsil epithelial tissue
culture is suitable for the replication of high titers of infectious,
native HPV16. This study focused on the assembly and infectivity
of infectious virus, suggesting that while many aspects of the
phenotype of HPV16 grown in foreskin and tonsil tissue are si-
milar, that there are signiﬁcant differences that relate to the ma-
turation and ﬁnal conformation of the virus when grown in the
two different tissues.Disclaimer
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